The Journal of Immunology, Vol 146, Issue 8 2659-2663, Copyright © 1991 by American Association of Immunologists

ARTICLES

H chain C domains influence the strength of binding of IgG for streptococcal group A carbohydrate

LJ Cooper, JC Schimenti, DD Glass and NS Greenspan
Institute of Pathology, Case Western Reserve University, Cleveland, OH 44106.

We have produced a panel of murine anti-streptococcal mAbs, expressing identical V domains and different H chain C domains, corresponding to the IgG3, IgG1, and IgG2b subclasses. We have used these mAb to evaluate the role of IgG subclass-specific C region determinants in modulating the interaction between antibody and the bacterial surface. We report, for the first time, that V region-identical murine IgG of different subclasses exhibit substantial differences in binding to specific Ag; IgG3 mAb binds more strongly to streptococci than the IgG1 and IgG2b mAb or IgG3-derived F(ab')2 fragments. Furthermore, the IgG3 mAB binds cooperatively to the bacteria, whereas the IgG1, IgG2b, and IgG3-derived F(ab')2 fragments do not exhibit significant cooperativity, which suggests that differences in Fc region structure can affect antibody binding to multivalent Ag by modulating the potential for cooperative binding. These results suggest a plausible mechanism by which murine IgG3 could be more effective, than other antibodies bearing identical V domains, but of different gamma- subclass, in mediating bacterial immunity.

This article has been cited by other articles:

				L. R. Miranda, M. Duval, H. Doherty, M. S. Seaman, M. R. Posner, and L. A. Cavacini The Neutralization Properties of a HIV-Specific Antibody Are Markedly Altered by Glycosylation Events Outside the Antigen-Binding Domain J. Immunol., June 1, 2007; 178(11): 7132 - 7138. [Abstract] [Full Text] [PDF]

				T. R. Kozel, P. Thorkildson, S. Brandt, W. H. Welch, J. A. Lovchik, D. P. AuCoin, J. Vilai, and C. R. Lyons Protective and Immunochemical Activities of Monoclonal Antibodies Reactive with the Bacillus anthracis Polypeptide Capsule Infect. Immun., January 1, 2007; 75(1): 152 - 163. [Abstract] [Full Text] [PDF]

				J. Rivera and A. Casadevall Mouse Genetic Background Is a Major Determinant of Isotype-Related Differences for Antibody-Mediated Protective Efficacy against Cryptococcus neoformans J. Immunol., June 15, 2005; 174(12): 8017 - 8026. [Abstract] [Full Text] [PDF]

				M. Torres, R. May, M. D. Scharff, and A. Casadevall Variable-Region-Identical Antibodies Differing in Isotype Demonstrate Differences in Fine Specificity and Idiotype J. Immunol., February 15, 2005; 174(4): 2132 - 2142. [Abstract] [Full Text] [PDF]

				M. D. Meeks, R. Saksena, X. Ma, T. K. Wade, R. K. Taylor, P. Kovac, and W. F. Wade Synthetic Fragments of Vibrio cholerae O1 Inaba O-Specific Polysaccharide Bound to a Protein Carrier Are Immunogenic in Mice but Do Not Induce Protective Antibodies Infect. Immun., July 1, 2004; 72(7): 4090 - 4101. [Abstract] [Full Text] [PDF]

				R. W. Maitta, K. Datta, A. Lees, S. S. Belouski, and L.-a. Pirofski Immunogenicity and Efficacy of Cryptococcus neoformans Capsular Polysaccharide Glucuronoxylomannan Peptide Mimotope-Protein Conjugates in Human Immunoglobulin Transgenic Mice Infect. Immun., January 1, 2004; 72(1): 196 - 208. [Abstract] [Full Text] [PDF]

				J. M. Lynch, D. E. Briles, and D. W. Metzger Increased Protection against Pneumococcal Disease by Mucosal Administration of Conjugate Vaccine plus Interleukin-12 Infect. Immun., August 1, 2003; 71(8): 4780 - 4788. [Abstract] [Full Text] [PDF]

				T. D. de Stahl, J. Dahlstrom, M. C. Carroll, and B. Heyman A Role for Complement in Feedback Enhancement of Antibody Responses by IgG3 J. Exp. Med., May 5, 2003; 197(9): 1183 - 1190. [Abstract] [Full Text] [PDF]

				E. M. Yoo, L. A. Wims, L. A. Chan, and S. L. Morrison Human IgG2 Can Form Covalent Dimers J. Immunol., March 15, 2003; 170(6): 3134 - 3138. [Abstract] [Full Text] [PDF]

				J. McLay, E. Leonard, S. Petersen, D. Shapiro, N. S. Greenspan, and J. R. Schreiber {gamma}3 Gene-Disrupted Mice Selectively Deficient in the Dominant IgG Subclass Made to Bacterial Polysaccharides. II. Increased Susceptibility to Fatal Pneumococcal Sepsis Due to Absence of Anti-Polysaccharide IgG3 Is Corrected by Induction of Anti-Polysaccharide IgG1 J. Immunol., April 1, 2002; 168(7): 3437 - 3443. [Abstract] [Full Text] [PDF]

				K. Westin Kwon, N. Lendvai, S. Morrison, K. R. Trinh, and A. Casadevall Biological Activity of a Mouse-Human Chimeric Immunoglobulin G2 Antibody to Cryptococcus neoformans Polysaccharide Clin. Vaccine Immunol., January 1, 2002; 9(1): 201 - 204. [Abstract] [Full Text] [PDF]

				R. S. Chu, T. McCool, N. S. Greenspan, J. R. Schreiber, and C. V. Harding CpG Oligodeoxynucleotides Act as Adjuvants for Pneumococcal Polysaccharide-Protein Conjugate Vaccines and Enhance Antipolysaccharide Immunoglobulin G2a (IgG2a) and IgG3 Antibodies Infect. Immun., March 1, 2000; 68(3): 1450 - 1456. [Abstract] [Full Text] [PDF]

				D. A. Shapiro, D. S. Threadgill, M. J. Copfer, D. A. Corey, T. L. McCool, L. L. McCormick, T. R. Magnuson, N. S. Greenspan, and J. R. Schreiber {gamma}3 Gene-Disrupted Mice Selectively Deficient in the Dominant IgG Subclass Made to Bacterial Polysaccharides Undergo Normal Isotype Switching After Immunization with Polysaccharide-Protein Conjugate Vaccines J. Immunol., October 1, 1998; 161(7): 3393 - 3399. [Abstract] [Full Text] [PDF]